Aster DM Healthcare Limited has announced an interim dividend for the financial year 2025–26, reinforcing its ongoing commitment to shareholder returns. The company’s Board has approved a dividend of ₹3 per equity share, with a face value of ₹10 each.
The payout is scheduled to be credited to eligible shareholders within 30 days from the date of declaration, in line with standard distribution timelines.
Key Dates for Dividend Eligibility
The company has fixed Friday, April 3, 2026, as the record date to identify shareholders entitled to receive the interim dividend. Investors whose names appear in the company’s records on this date will be eligible for the payout.
The ex-dividend date has been set as April 2, 2026. To qualify for the dividend, investors must ensure that they purchase the shares before this date. Any transactions executed on or after the ex-date will not be considered for the current dividend cycle, as they will not be settled in time to reflect in the shareholder register.
Track Record of Dividend Distribution
Aster DM Healthcare has demonstrated a consistent approach to rewarding its shareholders through regular dividend payouts. In August 2025, the company declared a final dividend of ₹1 per share, while an interim dividend of ₹4 per share was announced in February 2025.
Looking further back, the company issued a final dividend of ₹2 per share in August 2024. Notably, it also declared a special dividend of ₹118 per share in April 2024, marking one of its most significant payouts in recent years.
This steady dividend history underscores the company’s focus on maintaining a balanced capital allocation strategy while delivering value to its investors.
Summary
Aster DM Healthcare has announced a ₹3 interim dividend for FY 2025–26, with April 3, 2026, set as the record date and April 2, 2026, as the ex-date. The dividend will be paid within 30 days to eligible shareholders. The company’s consistent dividend track record, including regular and special payouts, reflects its strong commitment to shareholder value.
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.